Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.
Carmen NavarreteFrancisco Carrillo-SalinasBelén PalomaresMiriam MechaCarla Jiménez-JiménezLeyre MestreAna FeliúMaria L BellidoBernd L FiebichGiovanni AppendinoMarco A CalzadoCarmen GuazaEduardo MuñozPublished in: Journal of neuroinflammation (2018)
This study provides new significant insights about the potential role of VCE-004.8 for MS treatment by ameliorating neuroinflammation and demyelination.